New Insights Into the Comorbidity of Coronary Heart Disease and Depression

Curr Probl Cardiol. 2021 Mar;46(3):100413. doi: 10.1016/j.cpcardiol.2019.03.002. Epub 2019 Mar 12.

Abstract

Coronary heart disease (CHD) and depression are common disorders that markedly impair quality of life and impose a great financial burden on society. They are also frequently comorbid, exacerbating patient condition, and worsening prognosis. This comorbidity strongly suggests shared pathologic mechanisms. This review focuses on the incidence of depression in patients with CHD, deleterious effects of depression on CHD symptoms, and the potential mechanisms underlying comorbidity. In addition to the existing frequent mechanisms that are well known for decades, this review summarized interesting and original potential mechanisms to underlie the comorbidity, such as endocrine substances, gut microbiome, and microRNA. Finally, there are several treatment strategies for the comorbidity, involving drugs and psychotherapy, which may provide a theoretical basis for further basic research and clinical investigations on improved therapeutic interventions.

Publication types

  • Review

MeSH terms

  • Comorbidity
  • Coronary Disease* / epidemiology
  • Coronary Disease* / psychology
  • Coronary Disease* / therapy
  • Depression* / epidemiology
  • Depression* / therapy
  • Humans
  • Prognosis
  • Quality of Life